Literature DB >> 2463524

Natural and unnatural history of patients with severe carotid sinus hypersensitivity: a preliminary study.

M Brignole1, C Menozzi, G Lolli, B Sartore, M Barra.   

Abstract

Natural history of patients with symptomatic severe carotid sinus hypersensitivity is not clearly known. In order to evaluate the effectiveness of pacing therapy in these patients we performed a randomized treatment/no-treatment prospective study in 35 patients. They were randomly assigned to two groups: 19 patients received no therapy, 16 patients received a VVI (#11) or DDD (#5) pacemaker implant. During the 8.4 +/- 4.3 month follow-up period patients receiving no therapy had recurrence of syncope in 9 cases (47%) and minor symptoms in 13 (68%); at the 16th month, actuarial curve showed absence of syncope in 36% of patients and of any symptoms in 30%. During the 7.2 +/- 4.1 month follow-up period, the patients receiving the pacemaker implant had no recurrence of syncope, minor symptoms in three (19%); at the 16th month, actuarial curve showed absence of syncope in 100% of patients and of any symptoms in 78%. During follow-up, 12 patients in no-treatment group received a pacemaker implant because of the recurrence of severe symptoms; successively they had a strong reduction of symptoms. In conclusion, this study definitively demonstrates that patients with severe symptomatic carotid sinus hypersensitivity had a high rate of recurrence of spontaneous symptoms and that in these patients cardiac pacing is a useful therapy.

Entities:  

Mesh:

Year:  1988        PMID: 2463524     DOI: 10.1111/j.1540-8159.1988.tb06286.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  2 in total

Review 1.  The role of cardiac pacing in carotid sinus syndrome: a meta-analysis.

Authors:  Bing-Wei Chen; Zhi-Guang Wang; Na-Qiang Lv; Yan-Mei Cheng; Ai-Min Dang
Journal:  Clin Auton Res       Date:  2014-03-29       Impact factor: 4.435

Review 2.  Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

Authors:  Mohammed Qintar; Abdulrahman Morad; Hazem Alhawasli; Khaled Shorbaji; Belal Firwana; Adib Essali; Waleed Kadro
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.